$0.03 EPS Expected for Great Panther Silver Ltd (GPR); Axovant Sciences Ltd (AXON) Had 5 Analysts Last Week

July 21, 2017 - By Darrin Black

Among 7 analysts covering Axovant Sciences (NYSE:AXON), 5 have Buy rating, 1 Sell and 1 Hold. Therefore 71% are positive. Axovant Sciences had 9 analyst reports since September 25, 2015 according to SRatingsIntel. Chardan Capital Markets maintained the shares of AXON in report on Friday, September 25 with “Sell” rating. On Friday, January 8 the stock rating was initiated by H.C. Wainwright with “Buy”. The stock of Axovant Sciences Ltd (NYSE:AXON) has “Overweight” rating given on Thursday, April 13 by Piper Jaffray. Jefferies maintained it with “Buy” rating and $31 target in Wednesday, April 19 report. Oppenheimer maintained it with “Outperform” rating and $30 target in Wednesday, June 14 report. Piper Jaffray initiated Axovant Sciences Ltd (NYSE:AXON) on Thursday, October 22 with “Overweight” rating. The rating was initiated by Oppenheimer on Wednesday, December 7 with “Outperform”. The stock has “Outperform” rating by Leerink Swann on Tuesday, June 7. See Axovant Sciences Ltd (NYSE:AXON) latest ratings:

14/06/2017 Broker: Oppenheimer Rating: Outperform Old Target: $26.00 New Target: $30.00 Maintain
19/04/2017 Broker: IBC Rating: Neutral Old Target: $30.00 New Target: $33.00 Target Up
19/04/2017 Broker: Jefferies Rating: Buy New Target: $31.00 Maintain
13/04/2017 Broker: Piper Jaffray Rating: Overweight New Target: $32.00 Maintain

Analysts expect Great Panther Silver Ltd (TSE:GPR) to report $0.03 EPS on August, 2 after the close.T_GPR’s profit would be $5.03 million giving it 13.25 P/E if the $0.03 EPS is correct. After having $0.03 EPS previously, Great Panther Silver Ltd’s analysts see 0.00% EPS growth. About 36,746 shares traded. Great Panther Silver Ltd (TSE:GPR) has 0.00% since July 21, 2016 and is . It has underperformed by 16.70% the S&P500.

Great Panther Silver Ltd is a Canada silver mining and precious metals producer and exploration company. The company has market cap of $266.75 million. The Firm owns two producing mining operations: the Topia Mine and the Guanajuato Mine Complex (GMC). It has a 101.79 P/E ratio. The Company’s divisions include GMC, Topia, Exploration and Corporate.

About 351,442 shares traded. Axovant Sciences Ltd (NYSE:AXON) has risen 97.46% since July 21, 2016 and is uptrending. It has outperformed by 80.76% the S&P500.

Axovant Sciences Ltd. is a clinical-stage biopharmaceutical company. The company has market cap of $2.14 billion. The Firm is focused on acquiring, developing and commercializing therapeutics for the treatment of dementia, including Alzheimer’s disease and Lewy body dementia. It currently has negative earnings. The Firm intends to develop a pipeline of product candidates to address the cognitive, functional and behavioral aspects of dementia and related neurological disorders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Twitter Auto Publish Powered By : XYZScripts.com